What is the current valuation of the Skin Biopsy Market as of 2024?

The Skin Biopsy Market was valued at 149.87 USD Million in 2024. Read More

What is the projected market valuation for the Skin Biopsy Market in 2035?

The market is projected to reach 283.92 USD Million by 2035. Read More

What is the expected CAGR for the Skin Biopsy Market during the forecast period 2025 - 2035?

The expected CAGR for the Skin Biopsy Market during 2025 - 2035 is 5.94%. Read More

Which companies are considered key players in the Skin Biopsy Market?

Key players include DermTech, Aclaris Therapeutics, Histogenics Corporation, and others. Read More

What are the main applications of skin biopsies in the market?

The main applications include Diagnostic, Therapeutic, and Research, with valuations of 59.95, 44.92, and 45.0 USD Million respectively. Read More

How do the different types of skin biopsy compare in terms of market valuation?

Shave Biopsy leads with a valuation of 54.87 USD Million, followed by Punch Biopsy at 40.0 USD Million. Read More

What is the market valuation for skin biopsies by end use in 2024?

In 2024, Hospitals accounted for 59.95 USD Million, while Diagnostic Laboratories and Research Institutions followed with 44.92 and 45.0 USD Million respectively. Read More

What techniques are utilized in the Skin Biopsy Market?

The techniques include Surgical Biopsy, Needle Biopsy, and Endoscopic Biopsy, with Surgical Biopsy valued at 60.0 USD Million. Read More

What types of samples are analyzed in skin biopsies?

The sample types include Skin Lesions, Tumors, and Inflammatory Conditions, with Skin Lesions valued at 50.0 USD Million. Read More

How is the Skin Biopsy Market expected to evolve by 2035?

The market is likely to expand significantly, driven by advancements in technology and increasing demand for diagnostic procedures. Read More

Skin Biopsy Market

ID: MRFR/MED/3229-HCR

110 Pages

Vikita Thakur

Last Updated: April 24, 2026

Skin Biopsy Market Research Report By Procedure Type (Excisional Biopsy, Incisional Biopsy, Shave Biopsy, Punch Biopsy), By Type of Biopsy (Surgical Biopsy, Needle Biopsy, Liquid Biopsy), By End User (Diagnostic Laboratories, Hospitals, Research Institutions), By Application (Cancer Diagnosis, Infectious Disease Diagnosis, Autoimmune Disorders) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1.1 EXECUTIVE SUMMARY
1.1.1 Market Overview
1.1.2 Key Findings
1.1.3 Market Segmentation
1.1.4 Competitive Landscape
1.1.5 Challenges and Opportunities
1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
2.1 MARKET INTRODUCTION
2.1.1 Definition
2.1.2 Scope of the study
2.1.2.1 Research Objective
2.1.2.2 Assumption
2.1.2.3 Limitations
2.2 RESEARCH METHODOLOGY
2.2.1 Overview
2.2.2 Data Mining
2.2.3 Secondary Research
2.2.4 Primary Research
2.2.4.1 Primary Interviews and Information Gathering Process
2.2.4.2 Breakdown of Primary Respondents
2.2.5 Forecasting Model
2.2.6 Market Size Estimation
2.2.6.1 Bottom-Up Approach
2.2.6.2 Top-Down Approach
2.2.7 Data Triangulation
2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
3.1 MARKET DYNAMICS
3.1.1 Overview
3.1.2 Drivers
3.1.3 Restraints
3.1.4 Opportunities
3.2 MARKET FACTOR ANALYSIS
3.2.1 Value chain Analysis
3.2.2 Porter's Five Forces Analysis
3.2.2.1 Bargaining Power of Suppliers
3.2.2.2 Bargaining Power of Buyers
3.2.2.3 Threat of New Entrants
3.2.2.4 Threat of Substitutes
3.2.2.5 Intensity of Rivalry
3.2.3 COVID-19 Impact Analysis
3.2.3.1 Market Impact Analysis
3.2.3.2 Regional Impact
3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
4.1 Healthcare, BY Application (USD Million)
4.1.1 Diagnostic
4.1.2 Therapeutic
4.1.3 Research
4.2 Healthcare, BY Type (USD Million)
4.2.1 Excisional Biopsy
4.2.2 Incisional Biopsy
4.2.3 Punch Biopsy
4.2.4 Shave Biopsy
4.3 Healthcare, BY End Use (USD Million)
4.3.1 Hospitals
4.3.2 Diagnostic Laboratories
4.3.3 Research Institutions
4.4 Healthcare, BY Technique (USD Million)
4.4.1 Surgical Biopsy
4.4.2 Needle Biopsy
4.4.3 Endoscopic Biopsy
4.5 Healthcare, BY Sample Type (USD Million)
4.5.1 Skin Lesions
4.5.2 Tumors
4.5.3 Inflammatory Conditions
4.6 Healthcare, BY Region (USD Million)
4.6.1 North America
4.6.1.1 US
4.6.1.2 Canada
4.6.2 Europe
4.6.2.1 Germany
4.6.2.2 UK
4.6.2.3 France
4.6.2.4 Russia
4.6.2.5 Italy
4.6.2.6 Spain
4.6.2.7 Rest of Europe
4.6.3 APAC
4.6.3.1 China
4.6.3.2 India
4.6.3.3 Japan
4.6.3.4 South Korea
4.6.3.5 Malaysia
4.6.3.6 Thailand
4.6.3.7 Indonesia
4.6.3.8 Rest of APAC
4.6.4 South America
4.6.4.1 Brazil
4.6.4.2 Mexico
4.6.4.3 Argentina
4.6.4.4 Rest of South America
4.6.5 MEA
4.6.5.1 GCC Countries
4.6.5.2 South Africa
4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
5.1 Competitive Landscape
5.1.1 Overview
5.1.2 Competitive Analysis
5.1.3 Market share Analysis
5.1.4 Major Growth Strategy in the Healthcare
5.1.5 Competitive Benchmarking
5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
5.1.7 Key developments and growth strategies
5.1.7.1 New Product Launch/Service Deployment
5.1.7.2 Merger & Acquisitions
5.1.7.3 Joint Ventures
5.1.8 Major Players Financial Matrix
5.1.8.1 Sales and Operating Income
5.1.8.2 Major Players R&D Expenditure. 2023
5.2 Company Profiles
5.2.1 DermTech (US)
5.2.1.1 Financial Overview
5.2.1.2 Products Offered
5.2.1.3 Key Developments
5.2.1.4 SWOT Analysis
5.2.1.5 Key Strategies
5.2.2 Aclaris Therapeutics (US)
5.2.2.1 Financial Overview
5.2.2.2 Products Offered
5.2.2.3 Key Developments
5.2.2.4 SWOT Analysis
5.2.2.5 Key Strategies
5.2.3 Histogenics Corporation (US)
5.2.3.1 Financial Overview
5.2.3.2 Products Offered
5.2.3.3 Key Developments
5.2.3.4 SWOT Analysis
5.2.3.5 Key Strategies
5.2.4 MediWound Ltd. (IL)
5.2.4.1 Financial Overview
5.2.4.2 Products Offered
5.2.4.3 Key Developments
5.2.4.4 SWOT Analysis
5.2.4.5 Key Strategies
5.2.5 Sientra, Inc. (US)
5.2.5.1 Financial Overview
5.2.5.2 Products Offered
5.2.5.3 Key Developments
5.2.5.4 SWOT Analysis
5.2.5.5 Key Strategies
5.2.6 Avita Medical (AU)
5.2.6.1 Financial Overview
5.2.6.2 Products Offered
5.2.6.3 Key Developments
5.2.6.4 SWOT Analysis
5.2.6.5 Key Strategies
5.2.7 Tissue Regenix Group (GB)
5.2.7.1 Financial Overview
5.2.7.2 Products Offered
5.2.7.3 Key Developments
5.2.7.4 SWOT Analysis
5.2.7.5 Key Strategies
5.2.8 Elekta AB (SE)
5.2.8.1 Financial Overview
5.2.8.2 Products Offered
5.2.8.3 Key Developments
5.2.8.4 SWOT Analysis
5.2.8.5 Key Strategies
5.3 Appendix
5.3.1 References
5.3.2 Related Reports
6 LIST OF FIGURES
6.1 MARKET SYNOPSIS
6.2 NORTH AMERICA MARKET ANALYSIS
6.3 US MARKET ANALYSIS BY APPLICATION
6.4 US MARKET ANALYSIS BY TYPE
6.5 US MARKET ANALYSIS BY END USE
6.6 US MARKET ANALYSIS BY TECHNIQUE
6.7 US MARKET ANALYSIS BY SAMPLE TYPE
6.8 CANADA MARKET ANALYSIS BY APPLICATION
6.9 CANADA MARKET ANALYSIS BY TYPE
6.10 CANADA MARKET ANALYSIS BY END USE
6.11 CANADA MARKET ANALYSIS BY TECHNIQUE
6.12 CANADA MARKET ANALYSIS BY SAMPLE TYPE
6.13 EUROPE MARKET ANALYSIS
6.14 GERMANY MARKET ANALYSIS BY APPLICATION
6.15 GERMANY MARKET ANALYSIS BY TYPE
6.16 GERMANY MARKET ANALYSIS BY END USE
6.17 GERMANY MARKET ANALYSIS BY TECHNIQUE
6.18 GERMANY MARKET ANALYSIS BY SAMPLE TYPE
6.19 UK MARKET ANALYSIS BY APPLICATION
6.20 UK MARKET ANALYSIS BY TYPE
6.21 UK MARKET ANALYSIS BY END USE
6.22 UK MARKET ANALYSIS BY TECHNIQUE
6.23 UK MARKET ANALYSIS BY SAMPLE TYPE
6.24 FRANCE MARKET ANALYSIS BY APPLICATION
6.25 FRANCE MARKET ANALYSIS BY TYPE
6.26 FRANCE MARKET ANALYSIS BY END USE
6.27 FRANCE MARKET ANALYSIS BY TECHNIQUE
6.28 FRANCE MARKET ANALYSIS BY SAMPLE TYPE
6.29 RUSSIA MARKET ANALYSIS BY APPLICATION
6.30 RUSSIA MARKET ANALYSIS BY TYPE
6.31 RUSSIA MARKET ANALYSIS BY END USE
6.32 RUSSIA MARKET ANALYSIS BY TECHNIQUE
6.33 RUSSIA MARKET ANALYSIS BY SAMPLE TYPE
6.34 ITALY MARKET ANALYSIS BY APPLICATION
6.35 ITALY MARKET ANALYSIS BY TYPE
6.36 ITALY MARKET ANALYSIS BY END USE
6.37 ITALY MARKET ANALYSIS BY TECHNIQUE
6.38 ITALY MARKET ANALYSIS BY SAMPLE TYPE
6.39 SPAIN MARKET ANALYSIS BY APPLICATION
6.40 SPAIN MARKET ANALYSIS BY TYPE
6.41 SPAIN MARKET ANALYSIS BY END USE
6.42 SPAIN MARKET ANALYSIS BY TECHNIQUE
6.43 SPAIN MARKET ANALYSIS BY SAMPLE TYPE
6.44 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
6.45 REST OF EUROPE MARKET ANALYSIS BY TYPE
6.46 REST OF EUROPE MARKET ANALYSIS BY END USE
6.47 REST OF EUROPE MARKET ANALYSIS BY TECHNIQUE
6.48 REST OF EUROPE MARKET ANALYSIS BY SAMPLE TYPE
6.49 APAC MARKET ANALYSIS
6.50 CHINA MARKET ANALYSIS BY APPLICATION
6.51 CHINA MARKET ANALYSIS BY TYPE
6.52 CHINA MARKET ANALYSIS BY END USE
6.53 CHINA MARKET ANALYSIS BY TECHNIQUE
6.54 CHINA MARKET ANALYSIS BY SAMPLE TYPE
6.55 INDIA MARKET ANALYSIS BY APPLICATION
6.56 INDIA MARKET ANALYSIS BY TYPE
6.57 INDIA MARKET ANALYSIS BY END USE
6.58 INDIA MARKET ANALYSIS BY TECHNIQUE
6.59 INDIA MARKET ANALYSIS BY SAMPLE TYPE
6.60 JAPAN MARKET ANALYSIS BY APPLICATION
6.61 JAPAN MARKET ANALYSIS BY TYPE
6.62 JAPAN MARKET ANALYSIS BY END USE
6.63 JAPAN MARKET ANALYSIS BY TECHNIQUE
6.64 JAPAN MARKET ANALYSIS BY SAMPLE TYPE
6.65 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
6.66 SOUTH KOREA MARKET ANALYSIS BY TYPE
6.67 SOUTH KOREA MARKET ANALYSIS BY END USE
6.68 SOUTH KOREA MARKET ANALYSIS BY TECHNIQUE
6.69 SOUTH KOREA MARKET ANALYSIS BY SAMPLE TYPE
6.70 MALAYSIA MARKET ANALYSIS BY APPLICATION
6.71 MALAYSIA MARKET ANALYSIS BY TYPE
6.72 MALAYSIA MARKET ANALYSIS BY END USE
6.73 MALAYSIA MARKET ANALYSIS BY TECHNIQUE
6.74 MALAYSIA MARKET ANALYSIS BY SAMPLE TYPE
6.75 THAILAND MARKET ANALYSIS BY APPLICATION
6.76 THAILAND MARKET ANALYSIS BY TYPE
6.77 THAILAND MARKET ANALYSIS BY END USE
6.78 THAILAND MARKET ANALYSIS BY TECHNIQUE
6.79 THAILAND MARKET ANALYSIS BY SAMPLE TYPE
6.80 INDONESIA MARKET ANALYSIS BY APPLICATION
6.81 INDONESIA MARKET ANALYSIS BY TYPE
6.82 INDONESIA MARKET ANALYSIS BY END USE
6.83 INDONESIA MARKET ANALYSIS BY TECHNIQUE
6.84 INDONESIA MARKET ANALYSIS BY SAMPLE TYPE
6.85 REST OF APAC MARKET ANALYSIS BY APPLICATION
6.86 REST OF APAC MARKET ANALYSIS BY TYPE
6.87 REST OF APAC MARKET ANALYSIS BY END USE
6.88 REST OF APAC MARKET ANALYSIS BY TECHNIQUE
6.89 REST OF APAC MARKET ANALYSIS BY SAMPLE TYPE
6.90 SOUTH AMERICA MARKET ANALYSIS
6.91 BRAZIL MARKET ANALYSIS BY APPLICATION
6.92 BRAZIL MARKET ANALYSIS BY TYPE
6.93 BRAZIL MARKET ANALYSIS BY END USE
6.94 BRAZIL MARKET ANALYSIS BY TECHNIQUE
6.95 BRAZIL MARKET ANALYSIS BY SAMPLE TYPE
6.96 MEXICO MARKET ANALYSIS BY APPLICATION
6.97 MEXICO MARKET ANALYSIS BY TYPE
6.98 MEXICO MARKET ANALYSIS BY END USE
6.99 MEXICO MARKET ANALYSIS BY TECHNIQUE
6.100 MEXICO MARKET ANALYSIS BY SAMPLE TYPE
6.101 ARGENTINA MARKET ANALYSIS BY APPLICATION
6.102 ARGENTINA MARKET ANALYSIS BY TYPE
6.103 ARGENTINA MARKET ANALYSIS BY END USE
6.104 ARGENTINA MARKET ANALYSIS BY TECHNIQUE
6.105 ARGENTINA MARKET ANALYSIS BY SAMPLE TYPE
6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNIQUE
6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY SAMPLE TYPE
6.111 MEA MARKET ANALYSIS
6.112 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
6.113 GCC COUNTRIES MARKET ANALYSIS BY TYPE
6.114 GCC COUNTRIES MARKET ANALYSIS BY END USE
6.115 GCC COUNTRIES MARKET ANALYSIS BY TECHNIQUE
6.116 GCC COUNTRIES MARKET ANALYSIS BY SAMPLE TYPE
6.117 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
6.118 SOUTH AFRICA MARKET ANALYSIS BY TYPE
6.119 SOUTH AFRICA MARKET ANALYSIS BY END USE
6.120 SOUTH AFRICA MARKET ANALYSIS BY TECHNIQUE
6.121 SOUTH AFRICA MARKET ANALYSIS BY SAMPLE TYPE
6.122 REST OF MEA MARKET ANALYSIS BY APPLICATION
6.123 REST OF MEA MARKET ANALYSIS BY TYPE
6.124 REST OF MEA MARKET ANALYSIS BY END USE
6.125 REST OF MEA MARKET ANALYSIS BY TECHNIQUE
6.126 REST OF MEA MARKET ANALYSIS BY SAMPLE TYPE
6.127 KEY BUYING CRITERIA OF HEALTHCARE
6.128 RESEARCH PROCESS OF MRFR
6.129 DRO ANALYSIS OF HEALTHCARE
6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
6.133 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
6.134 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
6.135 HEALTHCARE, BY TYPE, 2024 (% SHARE)
6.136 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Million)
6.137 HEALTHCARE, BY END USE, 2024 (% SHARE)
6.138 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Million)
6.139 HEALTHCARE, BY TECHNIQUE, 2024 (% SHARE)
6.140 HEALTHCARE, BY TECHNIQUE, 2024 TO 2035 (USD Million)
6.141 HEALTHCARE, BY SAMPLE TYPE, 2024 (% SHARE)
6.142 HEALTHCARE, BY SAMPLE TYPE, 2024 TO 2035 (USD Million)
6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
7.1 LIST OF ASSUMPTIONS
7.1.1
7.2 North America MARKET SIZE ESTIMATES; FORECAST
7.2.1 BY APPLICATION, 2025-2035 (USD Million)
7.2.2 BY TYPE, 2025-2035 (USD Million)
7.2.3 BY END USE, 2025-2035 (USD Million)
7.2.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.2.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.3 US MARKET SIZE ESTIMATES; FORECAST
7.3.1 BY APPLICATION, 2025-2035 (USD Million)
7.3.2 BY TYPE, 2025-2035 (USD Million)
7.3.3 BY END USE, 2025-2035 (USD Million)
7.3.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.3.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.4 Canada MARKET SIZE ESTIMATES; FORECAST
7.4.1 BY APPLICATION, 2025-2035 (USD Million)
7.4.2 BY TYPE, 2025-2035 (USD Million)
7.4.3 BY END USE, 2025-2035 (USD Million)
7.4.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.4.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.5 Europe MARKET SIZE ESTIMATES; FORECAST
7.5.1 BY APPLICATION, 2025-2035 (USD Million)
7.5.2 BY TYPE, 2025-2035 (USD Million)
7.5.3 BY END USE, 2025-2035 (USD Million)
7.5.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.5.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.6 Germany MARKET SIZE ESTIMATES; FORECAST
7.6.1 BY APPLICATION, 2025-2035 (USD Million)
7.6.2 BY TYPE, 2025-2035 (USD Million)
7.6.3 BY END USE, 2025-2035 (USD Million)
7.6.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.6.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.7 UK MARKET SIZE ESTIMATES; FORECAST
7.7.1 BY APPLICATION, 2025-2035 (USD Million)
7.7.2 BY TYPE, 2025-2035 (USD Million)
7.7.3 BY END USE, 2025-2035 (USD Million)
7.7.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.7.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.8 France MARKET SIZE ESTIMATES; FORECAST
7.8.1 BY APPLICATION, 2025-2035 (USD Million)
7.8.2 BY TYPE, 2025-2035 (USD Million)
7.8.3 BY END USE, 2025-2035 (USD Million)
7.8.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.8.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.9 Russia MARKET SIZE ESTIMATES; FORECAST
7.9.1 BY APPLICATION, 2025-2035 (USD Million)
7.9.2 BY TYPE, 2025-2035 (USD Million)
7.9.3 BY END USE, 2025-2035 (USD Million)
7.9.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.9.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.10 Italy MARKET SIZE ESTIMATES; FORECAST
7.10.1 BY APPLICATION, 2025-2035 (USD Million)
7.10.2 BY TYPE, 2025-2035 (USD Million)
7.10.3 BY END USE, 2025-2035 (USD Million)
7.10.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.10.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.11 Spain MARKET SIZE ESTIMATES; FORECAST
7.11.1 BY APPLICATION, 2025-2035 (USD Million)
7.11.2 BY TYPE, 2025-2035 (USD Million)
7.11.3 BY END USE, 2025-2035 (USD Million)
7.11.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.11.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
7.12.1 BY APPLICATION, 2025-2035 (USD Million)
7.12.2 BY TYPE, 2025-2035 (USD Million)
7.12.3 BY END USE, 2025-2035 (USD Million)
7.12.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.12.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.13 APAC MARKET SIZE ESTIMATES; FORECAST
7.13.1 BY APPLICATION, 2025-2035 (USD Million)
7.13.2 BY TYPE, 2025-2035 (USD Million)
7.13.3 BY END USE, 2025-2035 (USD Million)
7.13.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.13.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.14 China MARKET SIZE ESTIMATES; FORECAST
7.14.1 BY APPLICATION, 2025-2035 (USD Million)
7.14.2 BY TYPE, 2025-2035 (USD Million)
7.14.3 BY END USE, 2025-2035 (USD Million)
7.14.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.14.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.15 India MARKET SIZE ESTIMATES; FORECAST
7.15.1 BY APPLICATION, 2025-2035 (USD Million)
7.15.2 BY TYPE, 2025-2035 (USD Million)
7.15.3 BY END USE, 2025-2035 (USD Million)
7.15.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.15.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.16 Japan MARKET SIZE ESTIMATES; FORECAST
7.16.1 BY APPLICATION, 2025-2035 (USD Million)
7.16.2 BY TYPE, 2025-2035 (USD Million)
7.16.3 BY END USE, 2025-2035 (USD Million)
7.16.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.16.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
7.17.1 BY APPLICATION, 2025-2035 (USD Million)
7.17.2 BY TYPE, 2025-2035 (USD Million)
7.17.3 BY END USE, 2025-2035 (USD Million)
7.17.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.17.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
7.18.1 BY APPLICATION, 2025-2035 (USD Million)
7.18.2 BY TYPE, 2025-2035 (USD Million)
7.18.3 BY END USE, 2025-2035 (USD Million)
7.18.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.18.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
7.19.1 BY APPLICATION, 2025-2035 (USD Million)
7.19.2 BY TYPE, 2025-2035 (USD Million)
7.19.3 BY END USE, 2025-2035 (USD Million)
7.19.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.19.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
7.20.1 BY APPLICATION, 2025-2035 (USD Million)
7.20.2 BY TYPE, 2025-2035 (USD Million)
7.20.3 BY END USE, 2025-2035 (USD Million)
7.20.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.20.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
7.21.1 BY APPLICATION, 2025-2035 (USD Million)
7.21.2 BY TYPE, 2025-2035 (USD Million)
7.21.3 BY END USE, 2025-2035 (USD Million)
7.21.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.21.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.22 South America MARKET SIZE ESTIMATES; FORECAST
7.22.1 BY APPLICATION, 2025-2035 (USD Million)
7.22.2 BY TYPE, 2025-2035 (USD Million)
7.22.3 BY END USE, 2025-2035 (USD Million)
7.22.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.22.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
7.23.1 BY APPLICATION, 2025-2035 (USD Million)
7.23.2 BY TYPE, 2025-2035 (USD Million)
7.23.3 BY END USE, 2025-2035 (USD Million)
7.23.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.23.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
7.24.1 BY APPLICATION, 2025-2035 (USD Million)
7.24.2 BY TYPE, 2025-2035 (USD Million)
7.24.3 BY END USE, 2025-2035 (USD Million)
7.24.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.24.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
7.25.1 BY APPLICATION, 2025-2035 (USD Million)
7.25.2 BY TYPE, 2025-2035 (USD Million)
7.25.3 BY END USE, 2025-2035 (USD Million)
7.25.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.25.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
7.26.1 BY APPLICATION, 2025-2035 (USD Million)
7.26.2 BY TYPE, 2025-2035 (USD Million)
7.26.3 BY END USE, 2025-2035 (USD Million)
7.26.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.26.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.27 MEA MARKET SIZE ESTIMATES; FORECAST
7.27.1 BY APPLICATION, 2025-2035 (USD Million)
7.27.2 BY TYPE, 2025-2035 (USD Million)
7.27.3 BY END USE, 2025-2035 (USD Million)
7.27.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.27.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
7.28.1 BY APPLICATION, 2025-2035 (USD Million)
7.28.2 BY TYPE, 2025-2035 (USD Million)
7.28.3 BY END USE, 2025-2035 (USD Million)
7.28.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.28.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
7.29.1 BY APPLICATION, 2025-2035 (USD Million)
7.29.2 BY TYPE, 2025-2035 (USD Million)
7.29.3 BY END USE, 2025-2035 (USD Million)
7.29.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.29.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
7.30.1 BY APPLICATION, 2025-2035 (USD Million)
7.30.2 BY TYPE, 2025-2035 (USD Million)
7.30.3 BY END USE, 2025-2035 (USD Million)
7.30.4 BY TECHNIQUE, 2025-2035 (USD Million)
7.30.5 BY SAMPLE TYPE, 2025-2035 (USD Million)
7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Application (USD Million, 2025-2035)

Diagnostic
Therapeutic
Research

Healthcare By Type (USD Million, 2025-2035)

Excisional Biopsy
Incisional Biopsy
Punch Biopsy
Shave Biopsy

Healthcare By End Use (USD Million, 2025-2035)

Hospitals
Diagnostic Laboratories
Research Institutions

Healthcare By Technique (USD Million, 2025-2035)

Surgical Biopsy
Needle Biopsy
Endoscopic Biopsy

Healthcare By Sample Type (USD Million, 2025-2035)

Skin Lesions
Tumors
Inflammatory Conditions

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓